Neuroglobin in Neuronal Hypoxi and Cerebral Ischemia
Neuroglobin in Neuronal Hypoxi and Cerebral Ischemia
批准号:
7589492
负责人:
David Alan Greenberg
金额:
$42.44万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2013-12-31
关键词:
AffectBindingBloodBrainBrain Hypoxia-IschemiaBrain InjuriesBrain IschemiaCell SurvivalCerebral InfarctionCerebral IschemiaCerebral Ischemia-HypoxiaCerebrumCobaltDNA DamageDeferoxamineDiseaseDissociationGlobinGoalsHemoglobinHypoxiaIn VitroInjuryIschemic Brain InjuryIschemic Neuronal InjuryIschemic-Hypoxic EncephalopathyLeadMediator of activation proteinMessenger RNAMiddle Cerebral Artery OcclusionMolecularMusMuscleMyoglobinNeuronal HypoxiaNeuronal InjuryNeuronsNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INitrogenNucleotidesOxygenPeroxonitriteProteinsResearchResistanceResponse ElementsRoleSeveritiesStrokeTestingTransgenic MiceTyrosineWorkbasecytotoxichypoxia inducible factor 1in vivoknock-downnervous system disorderneuroglobinneuroprotectionnitrationnovel therapeuticsoverexpressionpreventprotective effectprotein expressionpublic health relevanceresearch studytranscription factor
中文摘要
描述(由申请人提供):脑缺氧和缺血触发内源性保护机制,可预防或限制脑损伤。了解这些机制可能会导致中风和相关疾病的新的治疗策略。脑红蛋白(Ngb),最近发现的单体珠蛋白,是远亲血红蛋白和肌红蛋白,主要表达在脑神经元,并出现调节缺氧缺血性脑损伤。我们已经发现,神经元缺氧和脑缺血诱导Ngb表达,增强Ngb表达减少和敲低Ngb表达增加体外缺氧性神经元损伤和体内缺血性脑损伤,并且Ngb过表达转基因小鼠对大脑中动脉闭塞引起的脑梗死具有抗性。然而,Ngb对缺氧诱导的神经保护作用的机制尚不清楚。该应用基于Ngb是缺氧缺血性损伤的内源性神经保护的关键介质的假设,并且具有鉴定中风的新治疗的长期目标。该项目的具体目标是:(1)确定缺氧诱导因子-1(HIF-1)在体外缺氧诱导Ngb表达中的作用;(2)确定Ngb如何在体外保护神经元免受缺氧影响;(3)评估体外缺氧诱导Ngb和Ngb保护缺氧的机制在体内局灶性脑缺血期间重演的程度。公共卫生相关性:神经元缺氧和脑缺血激活保护机制,了解这些机制可能会导致中风的新治疗方法。脑红蛋白(Ngb)是最近发现的与血液血红蛋白和肌肉肌红蛋白相关的蛋白质,主要存在于大脑中。在以前的工作中,我们发现缺氧和缺血增加Ngb表达,这减少缺氧和缺血性神经元损伤,并且过度表达Ngb的小鼠对实验性中风具有抵抗力。在这个应用程序中,我们建议调查的机制,参与诱导Ngb的表达和Ngb的保护作用,集中在缺氧诱导因子-1和一氧化氮合酶的作用。这项研究的目标是找到治疗中风和相关神经系统疾病的新方法。
英文摘要
DESCRIPTION (provided by applicant): Cerebral hypoxia and ischemia trigger endogenous protective mechanisms that can prevent or limit brain damage. Understanding these mechanisms may lead to new therapeutic strategies for stroke and related disorders. Neuroglobin (Ngb), a recently discovered monomeric globin that is distantly related to hemoglobin and myoglobin, is expressed predominantly in brain neurons, and appears to modulate hypoxic-ischemic brain injury. We have found that neuronal hypoxia and cerebral ischemia induce Ngb expression, that enhancing Ngb expression reduces and knocking down Ngb expression increases hypoxic neuronal injury in vitro and ischemic cerebral injury in vivo, and that Ngb-overexpressing transgenic mice are resistant to cerebral infarction from occlusion of the middle cerebral artery. However, the mechanisms that underlie hypoxic induction of neuroprotection by Ngb are unknown. This application is based on the hypothesis that Ngb is a key mediator of endogenous neuroprotection from hypoxic-ischemic injury, and has the long-term goal of identifying new treatments for stroke. The specific aims of the proposed project are to: (1) Determine the role of hypoxia-inducible factor-1 (HIF-1) in hypoxic induction of Ngb expression in vitro; (2) Determine how Ngb protects neurons against hypoxia in vitro; and (3) Evaluate the extent to which mechanisms for hypoxic induction of Ngb and protection from hypoxia by Ngb in vitro are recapitulated during focal cerebral ischemia in vivo. PUBLIC HEALTH RELEVANCE: Neuronal hypoxia and brain ischemia activate protective mechanisms, and understanding these mechanisms may lead to new treatments for stroke. Neuroglobin (Ngb), a recently discovered protein related to blood hemoglobin and muscle myoglobin, is found primarily in the brain. In previous work, we found that hypoxia and ischemia increase Ngb expression, that this reduces hypoxic and ischemic neuronal injury, and that mice overexpressing Ngb are resistant to experimental stroke. In this application, we propose to investigate the mechanisms involved in the induction of Ngb expression and in Ngb's protective effects, concentrating on the roles of hypoxia-inducible factor-1 and nitric oxide synthases. The goal of this research is to find new ways to treat stroke and related neurological disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroglobin in Neuronal Hypoxi and Cerebral Ischemia
-
批准号:8207932
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2009
-
负责人:David Alan Greenberg
-
依托单位:
Neuroglobin in Neuronal Hypoxi and Cerebral Ischemia
-
批准号:8399022
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2009
-
负责人:David Alan Greenberg
-
依托单位:
Neuroglobin in Neuronal Hypoxi and Cerebral Ischemia
-
批准号:8009449
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2009
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) TL1
-
批准号:7502199
-
项目类别:
-
资助金额:$10.64万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Research Training and Education in Geroscience
-
批准号:7466726
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) RL9
-
批准号:7888163
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) TL1
-
批准号:7644958
-
项目类别:
-
资助金额:$10.86万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Neuronal Stem Cells and Aging
-
批准号:7643791
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) RL9
-
批准号:8097387
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) RL9
-
批准号:7502196
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Neuronal Stem Cells and Aging
-
批准号:8092824
-
项目类别:
-
资助金额:$43.21万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Neuronal Stem Cells and Aging
-
批准号:7501499
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) TL1
-
批准号:8097269
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Neuronal Stem Cells and Aging
-
批准号:7466669
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Neuronal Stem Cells and Aging
-
批准号:7877720
-
项目类别:
-
资助金额:$43.21万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) TL1
-
批准号:7888203
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Research Training and Education in Geroscience
-
批准号:7466716
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
Postdoctoral Reearch Training and Education in Geroscience (10 of 11) RL9
-
批准号:7644951
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2007
-
负责人:David Alan Greenberg
-
依托单位:
New Gene Expression in Cell Culture Models of Ischemia
-
批准号:6779018
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2003
-
负责人:David Alan Greenberg
-
依托单位:
VEGF in Neurprotection and Neurogenesis
-
批准号:6821365
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2002
-
负责人:David Alan Greenberg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: